Maglangit, Isaac T.

HRN: 28-68-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/11/2026
03/17/2026
IV
750mg
OD
CAP HR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTIProphylaxis    Compliance to guidelines: Compliant To Guidelines